header logo image

Myriad Genetics Get 2 Patents for Molecular Residual Disease Assay

February 7th, 2025 2:52 am

Market Closed - Nasdaq 04:00:00 2025-02-06 pm EST 5-day change 1st Jan Change 12.73 USD -1.55% -1.39% -7.15%

February 05, 2025 at 05:41 pm EST

To unlock the article, REGISTER!

DurationAuto.2 months3 months6 months9 months1 year2 years5 years10 yearsMax.

PeriodDayWeek

Last Close Price

12.73USD

Average target price

19.54USD

Spread / Average Target

+53.48%

+951% of historicalperformance

More than 20 yearsat your side

Our Expertsare here for you

OUR EXPERTS ARE HERE FOR YOU

Monday - Friday 9am-12pm / 2pm-6pm GMT + 1

Stock quotes are provided by Factset, Morningstar and S&P Capital IQ

View post:
Myriad Genetics Get 2 Patents for Molecular Residual Disease Assay

Related Post

Tags:

Comments are closed.


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick